Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
2,169
Total Claims
$501K
Drug Cost
115
Beneficiaries
$4,359
Cost/Patient
Risk Score Breakdown 14/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
+464%
Opioid rate vs peers
7.4% vs 1.3% avg
+8%
Cost per patient vs peers
$4,359 vs $4,034 avg
+89%
Brand preference vs peers
17.8% vs 9.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
7.4%
Opioid Rate
160
Opioid Claims
$17K
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 383 claims · $437K
Generic: 1,774 claims · $64K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rimegepant Sulfate | 65 | $122K |
| Onabotulinumtoxina | 72 | $96K |
| Erenumab-Aooe | 81 | $64K |
| Ubrogepant | 30 | $43K |
| Fremanezumab-Vfrm | 31 | $23K |
| Galcanezumab-Gnlm | 19 | $21K |
| Atogepant | 19 | $21K |
| Oxycodone Hcl/Acetaminophen | 27 | $16K |
| Butorphanol Tartrate | 104 | $13K |
| Lisdexamfetamine Dimesylate | 11 | $4,350 |
| Sumatriptan Succinate | 121 | $3,645 |
| Butalb/Acetaminophen/Caffeine | 169 | $3,087 |
| Chlorpromazine Hcl | 47 | $2,773 |
| Sumatriptan | 14 | $2,304 |
| Levetiracetam | 70 | $2,150 |
Prescribing Profile
52
Unique Drugs
14.0
Anomaly Score
Patient Profile
62
Avg Age
79%
Female
1.40
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About